Oxymorphone Patch Meets Phase 1 End Points
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- POH Topical Oxycodone Patch Alleviates Pain in Racehorses
- Phosphagenics - TPM in Dairy Feed Inclusion Technology
- Phosphagenics Oxymorphone Patch Success
- Oxymorphone Pain Relief Patch - Multi-Dose Trial
- Opioid Patch Program Update
Later from Avecho Biotechnology
- December 2011 Preliminary Final and Audited Financial Report
- Korean Distribution Agreement for BioElixia
- Neura Therapeutik Appointed as US Strategic Advisors
- Pivotal TPM-oxycodone Patch Trials Begin
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology